Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol on Walking Capacity in COPD
NCT00525564Phase 4Completed
- Sponsor
- Université Laval
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Université Laval. Started May 2006; status: completed.
02
Drugs
salmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00525564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00525564.